BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 6226655)

  • 1. The effects of fibrinogen and its cleavage products on the kinetics of plasminogen activation by urokinase and subsequent plasmin activity.
    Lucas MA; Straight DL; Fretto LJ; McKee PA
    J Biol Chem; 1983 Oct; 258(20):12171-7. PubMed ID: 6226655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic analyses of the activation of Glu-plasminogen by urokinase in the presence of fibrin, fibrinogen or its degradation products.
    Watahiki Y; Takada Y; Takada A
    Thromb Res; 1987 Apr; 46(1):9-18. PubMed ID: 3590117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fragment E-2 from fibrin substantially enhances pro-urokinase-induced Glu-plasminogen activation. A kinetic study using the plasmin-resistant mutant pro-urokinase Ala-158-rpro-UK.
    Liu JN; Gurewich V
    Biochemistry; 1992 Jul; 31(27):6311-7. PubMed ID: 1385727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A transitional state of pro-urokinase that has a higher catalytic efficiency against glu-plasminogen than urokinase.
    Liu JN; Pannell R; Gurewich V
    J Biol Chem; 1992 Aug; 267(22):15289-92. PubMed ID: 1639775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of staphylokinase with different molecular forms of plasminogen.
    Lijnen HR; Van Hoef B; Collen D
    Eur J Biochem; 1993 Jan; 211(1-2):91-7. PubMed ID: 8425556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Binding of Glu-plasminogen by fibrinogen and byproducts of its proteolysis].
    Grinenko TV; Tret'iachenko VG; Skomorovskaia EV; Kudinov SA
    Biokhimiia; 1989 Feb; 54(2):213-20. PubMed ID: 2525932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinolysis and fibrinogenolysis by Val442-plasmin.
    Ney KA; Pizzo SV
    Biochim Biophys Acta; 1982 Nov; 708(2):218-24. PubMed ID: 6216916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of the urokinase-catalyzed activation of human plasminogen.
    Violand BN; Castellino FJ
    J Biol Chem; 1976 Jul; 251(13):3906-12. PubMed ID: 132442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A battery of monoclonal antibodies that induce unique conformations to evolve cryptic but constitutive functions of plasminogen.
    Madoiwa S; Arai K; Ueda Y; Ishizuka M; Mimuro J; Asakura S; Matsuda M; Sakata Y
    J Biochem; 1997 Feb; 121(2):278-87. PubMed ID: 9089401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino-terminal fragment of urokinase-type plasminogen activator inhibits its plasminogen activation.
    Sun Z; Zhang PX; Wang P; Gurewich V; Shen HY; Liu JN
    Thromb Res; 2002 Apr; 106(2):105-11. PubMed ID: 12182908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequence of formation of molecular forms of plasminogen and plasmin-inhibitor complexes in plasma activated by urokinase or tissue-type plasminogen activator.
    Thorsen S; Müllertz S; Suenson E; Kok P
    Biochem J; 1984 Oct; 223(1):179-87. PubMed ID: 6208894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasminogen activation by single-chain urokinase in functional isolation. A kinetic study.
    Ellis V; Scully MF; Kakkar VV
    J Biol Chem; 1987 Nov; 262(31):14998-5003. PubMed ID: 3667621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation pathway of glu-plasminogen to Lys-plasmin by urokinase.
    Takada A; Takada Y
    Thromb Res; 1982 Sep; 27(6):671-7. PubMed ID: 6129717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary-site binding of Glu-plasmin, Lys-plasmin and miniplasmin to fibrin.
    Suenson E; Thorsen S
    Biochem J; 1981 Sep; 197(3):619-28. PubMed ID: 6459779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The kinetics of plasminogen activation by thrombin-cleaved pro-urokinase and promotion of its activity by fibrin fragment E-2 and by tissue plasminogen activator.
    Liu JN; Gurewich V
    Blood; 1993 Feb; 81(4):980-7. PubMed ID: 8428004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of the synergistic effect between oversulfated chondroitin-6-sulfate and lysine or 6-aminohexanoic acid in enhancing the in-vitro activation of glutamic plasminogen by tissue plasminogen activator or urokinase.
    Kouemo S; McMillan E; Doctor V
    Blood Coagul Fibrinolysis; 2010 Jul; 21(5):425-30. PubMed ID: 20445443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the specific interaction between the lysine-binding sites in plasmin and complementary sites in alpha2-antiplasmin and in fibrinogen.
    Wiman B; Lijnen HR; Collen D
    Biochim Biophys Acta; 1979 Jul; 579(1):142-54. PubMed ID: 157166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of human fibrinogen and its cleavage products on activation of human plasminogen by streptokinase.
    Chibber BA; Morris JP; Castellino FJ
    Biochemistry; 1985 Jul; 24(14):3429-34. PubMed ID: 4041421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The blockage of the high-affinity lysine binding sites of plasminogen by EACA significantly inhibits prourokinase-induced plasminogen activation.
    Sun Z; Chen YH; Wang P; Zhang J; Gurewich V; Zhang P; Liu JN
    Biochim Biophys Acta; 2002 Apr; 1596(2):182-92. PubMed ID: 12007600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the cyanogen-bromide-2 fragment of fibrinogen on plasminogen activation by single-chain urokinase-type plasminogen activator.
    Kirchheimer JC; Resch I; Christ G; Wojta J; Binder BR
    Eur J Biochem; 1987 Jul; 166(2):393-7. PubMed ID: 3609016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.